► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />Activist investor Dan Loeb wants the biotechnology company Amgen to think about splitting into two. Lex's Oliver Ralph and Robert Armstrong discuss why splits are advocated and whether it would work in Amgen's case.<br /><br />For more video content from the Financial Times, visit http://www.FT.com/video<br /><br />Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k<br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes
